Herceptin trastuzumab: Phase III trials updated

Genentech Inc. (DNA), South San Francisco, Calif.
Product: Herceptin trastuzumab
Business: Cancer

Read the full 127 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE